GLOW-CRISPR: A G-Quadruplex Loop-Engineered Optical Workflow Combined with CRISPR-Cas12a System for SARS-CoV-2 Detection

Authors: Shi, Wenyang; Lin, Xiaodong; Li, Xiang; Pal, Tathagata; Liu, Benjamin M; Chen, Juhong

Source journal: Analytical chemistry (2026-11-17)

DOI: 10.1021/acs.analchem.6c05407

Abstract

SARS-CoV-2 remains a serious public health threat, highlighting the need for rapid and accessible nucleic-acid diagnostics for decentralized testing. CRISPR-Cas systems are promising platforms for viral diagnostics because of their high specificity and compatibility with isothermal workflows. However, many CRISPR-based assays still rely on labelled reporters, dedicated fluorescence instrumentation, or single-mode outputs that increase cost and limit field deployment. Herein, we developed a label-free GLOW-CRISPR assay (a G-quadruplex loop-engineered optical workflow combined with the CRISPR-Cas12a system) to detect SARS-CoV-2. The assay provides fluorescence and colorimetric readouts in separate endpoint workflows through loop-engineered G4 reporters. Upon recognition of the SARS-CoV-2 target, activated Cas12a cleaves the loop-engineered G4 reporters, thereby suppressing both fluorescence and colorimetric signals. Using optimized conditions, the GLOW-CRISPR assay achieved limits of detection of 7.7 nM and 2.9 nM for fluorescence and colorimetric readouts, respectively. It also showed no detectable cross-reactivity with non-target respiratory viruses and correctly classified patient-derived nasopharyngeal samples in concordance with RT-qPCR results. Collectively, these results establish G4 loop engineering as a general strategy for label-free CRISPR-Cas12a signal transduction without probe labelling or specialized instrumentation. By expanding optical readout flexibility while reducing assay cost and complexity, the GLOW-CRISPR assay provides a practical framework for decentralized molecular diagnostics in resource-limited settings.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.